Ionis maintained at SELL by Citigroup PT $28 | IONS Message Board Posts


Ionis Pharmaceuticals, Inc.

  IONS website

IONS   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  62164 of 62238  at  8/14/2022 8:18:41 AM  by

acidbather


 In response to msg 62163 by  riverwalk
view thread

Re: Ionis maintained at SELL by Citigroup PT $28

Goldman Sachs may be a tad lower, but so what? Eplontersen, with AstraZeneca behind it, could be a game changer for Ionis shareholders. It should be bigger than Spinraza, especially the CV indication. And there are other CV drugs that will conclude their marathon trials in the next 2 or 3 years. They wont all fail. The orphan drug for HAE, wholly owned, will be another significant income generator in the same 2 to 3 year time frame. So, Im not buying the cynicism of the PT in the mid 20s. Neither should you.


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 1  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
62169 Re: Ionis maintained at SELL by Citigroup PT $28 arthurs1 1 8/16/2022 2:33:47 PM




Financial Market Data provided by
.
Loading...